| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | 1 | 1 | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 0.68 |
—
—
—
|
| 2025 | 0.62 |
—
—
—
—
|
| 2024 | 0.54 |
—
—
—
—
|
| 2023 | 0.48 |
—
—
—
—
|
| 2022 | 0.42 |
—
—
—
—
|
| 2021 | 0.38 |
—
—
—
—
|
| 2020 | 0.35 |
—
—
—
—
|
| 2019 | 0.33 |
—
—
—
—
|
| 2018 | 0.31 |
—
—
—
—
|
| 2017 | 0.28 |
—
—
—
—
|
| 2016 | 0.25 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 2,303.00 | 2,502.00 | 3,550.00 | 3,531.00 |
| Receivables | 2,040.00 | 3,538.00 | 3,600.00 | 3,770.00 |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 4,343.00 | 6,040.00 | 7,150.00 | 7,301.00 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 1,052.00 | 2,493.00 | 2,714.00 | 2,372.00 |
| ST’ Debt | 569.00 | 225.00 | 719.00 | 413.00 |
| Other | — | — | — | — |
| 2,229.00 | 3,371.00 | 4,308.00 | 3,468.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1,901.00 | 1,676.00 | — | — |
—
|
| ’25 | 1,404.00 | 1,285.00 | 1,606.00 | 1,607.00 |
5,902.00
|
| ’24 | 1,258.00 | 1,178.00 | 1,186.00 | 1,183.00 |
4,805.00
|
| ’23 | 1,116.00 | 1,047.00 | 1,068.00 | 1,026.00 |
4,257.00
|
| ’22 | 904.70 | 839.70 | 927.60 | 901.00 |
3,573.00
|
| ’21 | 815.30 | 727.30 | 770.30 | 738.50 |
3,051.40
|
| ’20 | 698.50 | 598.81 | 673.96 | 642.14 |
2,613.40
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 262.00 | 346.00 | — | — |
—
|
| ’25 | 213.00 | 325.00 | 468.00 | 444.00 |
1,450.00
|
| ’24 | 13.00 | 360.00 | 440.00 | 361.00 |
1,174.00
|
| ’23 | 60.00 | 328.00 | 316.00 | 306.00 |
1,010.00
|
| ’22 | 103.60 | 242.60 | 253.60 | 281.20 |
881.00
|
| ’21 | 138.00 | 241.90 | 247.90 | 181.00 |
808.80
|
| ’20 | 33.82 | 382.88 | 122.89 | 173.41 |
713.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 241.00 | 332.00 | — | — |
—
|
| ’25 | 205.00 | 311.00 | 452.00 | 423.00 |
1,391.00
|
| ’24 | 0.00 | 392.00 | 419.00 | 351.00 |
1,162.00
|
| ’23 | 54.00 | 315.00 | 305.00 | 374.00 |
1,048.00
|
| ’22 | 93.80 | 238.50 | 237.30 | 319.40 |
889.00
|
| ’21 | 126.80 | 236.30 | 239.40 | 177.90 |
780.40
|
| ’20 | 17.74 | 363.31 | 111.33 | 159.51 |
651.90
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1.06 | 0.84 | — | — |
—
|
| ’25 | 1.15 | 0.78 | 0.68 | 0.59 |
3.16
|
| ’24 | 1.02 | 0.90 | 0.81 | 0.73 |
3.46
|
| ’23 | 0.83 | 0.67 | 0.62 | 0.94 |
3.05
|
| ’22 | 0.77 | 0.51 | 0.57 | 0.51 |
2.37
|
| ’21 | 0.70 | 0.49 | 0.52 | 0.36 |
2.07
|
| ’20 | 0.54 | 0.34 | 0.47 | 0.34 |
1.69
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 52.91 | 52.82 | 69.24 | 76.17 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 74.00 | 76.25 | 114.15 | 125.68 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15,201 | 9,705 | 17,403 | 7,905 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.24 | 0.44 | 0.28 | 0.75 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,573.00 | 4,257.00 | 4,805.00 | 5,902.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 49.15% | 48.63% | 49.93% | 50.27% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 876.00 | 1,146.00 | 1,303.00 | 1,371.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 24.52% | 26.92% | 27.12% | 23.23% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 672.00 | 871.00 | 1,002.00 | 1,067.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 182.00 | 66.00 | 193.00 | 370.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.85 | 15.20 | 17.04 | 19.04 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | 2.38 | 3.07 | 3.48 | 3.37 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.17 | 3.61 | 4.16 | 4.68 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.03 | 0.14 | (0.04) | (0.19) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.20 | 3.74 | 4.12 | 4.49 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.57 | 19.93 | 22.83 | 40.56 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 278.00 | 280.00 | 282.00 | 310.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 23.90 | 23.12 | 29.32 | 23.37 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.41 | 4.65 | 5.99 | 4.19 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.42 | 3.55 | 4.47 | 1.97 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.94 | 5.00 | 6.26 | 4.87 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.86 | 20.33 | 25.90 | 20.68 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 881.00 | 1,010.00 | 1,174.00 | 1,450.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.00 | 38.00 | (12.00) | (59.00) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 889.00 | 1,048.00 | 1,162.00 | 1,391.00 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,056.50 | 2,114.00 | 2,669.00 | 2,842.00 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,942.10 | 3,796.00 | 3,824.00 | 7,613.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,908.90 | 1,493.00 | 1,322.00 | 4,063.00 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,606.60 | 5,579.00 | 6,437.00 | 12,573.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.55% | 5.95% | 6.04% | 4.38% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.40% | 10.13% | 10.50% | 5.15% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.97% | 16.85% | 16.33% | 10.97% | — | — | — |
ROE
|
Brown & Brown, Inc. (BRO) has engineered explosive growth, skyrocketing revenue from $1.77 billion in 2016 to $4.81 billion in 2024 at a stellar 13% CAGR, fueled by savvy M&A like the Hays deal and organic brokerage resilience—even thriving through COVID. Profitability shines with net income tripling to $1 billion, EPS surging 278% to $3.48, and ROE hitting 16.3%, while free cash flow per share more than doubled to $4.12. Trading 20% below analyst targets amid premium valuations (forward PE ~20x), BRO boasts massive upside potential, with forecasts eyeing $8 billion revenue and $4.25 EPS by 2028—a 67% revenue leap driven by relentless dealmaking and hardening insurance rates.
Yet, this powerhouse isn’t without hurdles: debt has ballooned to fund acquisitions, net debt projected to double in 2025, and employee volatility hints at integration tests. Insider buys signal confidence, with no sells, and the stock’s 388% low-to-low advance underscores its defensive mojo. For growth seekers, BRO’s quality trajectory screams opportunity—20%+ mean upside awaits flawless execution in a digitalizing industry.
Dive into the full analysis for charts, peer comps, and the M&A playbook propelling this brokerage behemoth forward!
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.